ENTERA BIO LTD (ENTX)
IL0011429839 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | N/A | |||
| Cash Equivalents | 11.02M | 12.31M | 24.89M | 8.59M | 15.19M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | 0.00 | |||
| Receivables | 0.00 | 250.00K | 180.00K | 260.00K | 280.00K | |||
| Other Current Assets | 238.00K | 290.00K | 250.00K | 260.00K | 170.00K | |||
| Total Current Assets | 11.26M | 12.85M | 25.33M | 9.11M | 15.64M | |||
| Non-Current Assets | ||||||||
| PPE Net | 488.00K | 230.00K | 400.00K | 570.00K | 460.00K | |||
| Intangibles | N/A | N/A | N/A | 610.00K | 610.00K | |||
| Other Non-Current Assets | 20.00K | 50.00K | 260.00K | 50.00K | N/A | |||
| Total Non-Current Assets | 508.00K | 280.00K | 660.00K | 610.00K | 1.06M | |||
| TOTAL ASSETS | 11.77M | 13.13M | 25.99M | 9.72M | 16.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | 190.00K | 180.00K | |||
| Accrued Expenses | 1.01M | 1.32M | 2.98M | 1.52M | 1.14M | |||
| Accounts Payable | 83.00K | 20.00K | 170.00K | 160.00K | 330.00K | |||
| Other Current Liabilities | N/A | 0.00 | 20.00K | 160.00K | 2.94M | |||
| Total Current Liabilities | 1.09M | 1.34M | 3.16M | 1.84M | 4.59M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 120.00K | |||
| Other Non-Current Liabilities | 288.00K | 30.00K | 260.00K | 370.00K | 70.00K | |||
| Total Non-Current Liabilities | 288.00K | 30.00K | 260.00K | 370.00K | 190.00K | |||
| TOTAL LIABILITIES | 1.38M | 1.37M | 3.42M | 2.21M | 4.78M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -104.39M | -95.50M | -82.43M | -70.24M | -51.51M | |||
| Additional Paid In Capital | 114.73M | 107.21M | 104.95M | 77.71M | 63.39M | |||
| Common Shares | 2.73K | N/A | N/A | N/A | N/A | |||
| Other Shareholders' Equity | 39.27K | 40.00K | 40.00K | 40.00K | 40.00K | |||
| Shares Outstanding | 35.48M | 28.81M | 28.80M | 21.06M | 17.86M | |||
| Tangible Book Value per Share | 0.29 | 0.41 | 0.78 | 0.36 | 0.63 | |||
| Total Shareholders' Equity | 10.39M | 11.75M | 22.57M | 7.51M | 11.92M | |||
| TOTAL LIABILITIES AND EQUITY | 11.77M | 13.13M | 25.99M | 9.72M | 16.70M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | 0.01 | |||
| Current Ratio | 10.32 | 9.59 | 8.02 | 4.95 | 3.41 | |||
| Return On Assets (ROA) | -75.55% | -99.54% | -46.90% | -115.43% | -64.67% | |||
| Return On Equity (ROE) | -85.59% | -111.23% | -54.01% | -149.40% | -90.60% | |||
All data in USD